Rochester Manor OpCo LLC and three affiliates have court approval to run a competitive sale process for their care-facility operations under a stalking-horse agreement with no cash purchase price. The September 24, 2026 order approved bidding procedures, the stalking horse and bid protections. A separate sale hearing is scheduled for November 19, following a conditional November 11 auction. The reviewed evidence through October 3 does not establish that a sale has closed. Sale motion, pp. 8–11; bidding procedures order, pp. 3–8; October 1 amended sale notice, pp. 1–3.
The debtors describe the proposed transaction's value in terms of employment continuity, specified liability assumptions, provider arrangements and cure-cost payments. An October 1 preliminary schedule lists approximately $14.1 million in estimated petition-date rent arrears, but assumption remains subject to negotiated cure terms and verification. That amount is neither a cash purchase price nor a guaranteed recovery for landlords. Sale motion, pp. 8–11; .
The stalking-horse group consists of Arm Operating LLC, RM Operating LLC, RMV Operating LLC and SH Operating LLC. The September 16 sale motion proposes transferring substantially all operating assets to those entities, subject to competing bids. Preclosing accounts receivable and avoidance actions are excluded. The debtors lease their facilities from nondebtor property companies and do not own the underlying real estate. Sale motion, pp. 5–11.
The restructuring concerns nursing and personal-care operations in Rochester, Kittanning and Pittsburgh. The debtors attribute their distress to rising labor costs, staffing shortages, Medicaid reimbursement rates below care costs, payment delays and occupancy pressures. These are the debtors' explanations in the sale motion. Sale motion, pp. 5–8.
Rent assumption remains conditional
The October 1 preliminary assumed-liabilities schedule lists estimated petition-date rent arrears for the facility groups. Assumption remains subject to negotiated cure terms, and the amounts remain subject to verification. The schedule does not establish an unconditional payment obligation or guaranteed recovery. Preliminary assumed-liabilities schedule, Exhibit A.
Facility lease group
Estimated petition-date rent arrears, USD
Rochester Manor and Rochester Villa, combined
$5,578,788
Spring Hill
$3,421,509
Armstrong
$5,126,112
Calculated total
$14,126,409
Preliminary Petition-Date Rent Arrears
The total is calculated by adding the three U.S.-dollar estimates in the October 1 schedule. It measures listed rent arrears; it does not establish a negotiated cure payment, the value of all assumed liabilities or cash sale proceeds.
Because assumption depends on negotiated cure terms and verification, the preliminary total does not establish that the full listed balance will be paid at closing. Preliminary assumed-liabilities schedule, Exhibit A.
Approved bidder protections
The entered bidding procedures order approved a termination fee equal to 3% of total consideration under the stalking-horse operating transfer agreement, inclusive of expense reimbursement. If payable, the fee comes solely from the proceeds of an alternative transaction at its closing. The approved formula differs from the motion's requested fee of the greater of $125,000 or 3% of consideration. Approval of these protections and the sale process does not establish that the sale itself has been completed. Bidding procedures order, pp. 3–8.
The October 1 second interim financing order describes a Sapira1 LLC debtor-in-possession facility of up to $4.6 million: $1.7 million of interim availability and an additional $2.9 million contingent on entry of a final order. The stated annual interest rate is 12%, increasing to 16% during a continuing default. These figures describe authorized capacity and conditional availability, rather than evidence of amounts actually drawn. Second interim financing order, pp. 2–3.
The order also permits budget-governed cash-collateral use and grants DIP liens and superpriority status subject to specified exclusions and the carve-out. The committee's and U.S. Trustee's objections are preserved for the final financing hearing. This remains interim relief; the final hearing is scheduled for October 15, 2026, at 11:30 a.m. Second interim financing order, pp. 4–7 and docket entry.
Scheduled sale milestones
The following milestones reflect the September 24 order and October 1 amended sale notice. They are prospective dates, not completed outcomes. The sale hearing remains subject to further court scheduling. Bidding procedures order, pp. 6–8; amended sale notice, pp. 1–3.
Date
Scheduled milestone
November 6, 2026, noon ET
Qualified bid deadline
November 11, 2026, 10 a.m. ET
Conditional auction
November 19, 2026, 3:30 p.m. ET
Hearing to consider sale approval
By November 20, 2026
Target sale-order entry
By December 1, 2026
Target closing
Selected Scheduled Sale Milestones
Without an additional qualifying bid, the amended notice contemplates canceling the auction and seeking approval of the stalking horse. Any eventual transaction must still be assessed against its final liability-assumption and cure terms; the preliminary rent schedule does not establish completed payments or definitive transaction value. Amended sale notice, pp. 1–3; preliminary assumed-liabilities schedule, Exhibit A.
Sources
Sale motion, pp. 8–11 /documents/677a067b-adc1-4c3f-ac1e-eebd60626f0f/
bidding procedures order, pp. 3–8 /documents/4abcb293-277a-407e-a0da-ebd6f348c71d/
October 1 amended sale notice, pp. 1–3 /documents/feb99ec2-11f8-47b8-9056-0a50bbdd70cb/
preliminary assumed-liabilities schedule, Exhibit A /documents/a167f736-27cf-445e-9c61-ce71eab1b4ce/
Second interim financing order, pp. 2–3 /documents/1a8c005b-2021-4a0f-8c01-e2846a90f413/
This article was researched and written with AI assistance, using court filings, public records, and news sources. AI-generated content can contain errors. Verify all information against primary sources before relying on it. This is not legal or financial advice. See the disclaimer.